Efficacy of NS-018, a potent and selective JAK2/Src inhibitor, in primary cells and mouse models of myeloproliferative neoplasms
出版年份 2011 全文链接
标题
Efficacy of NS-018, a potent and selective JAK2/Src inhibitor, in primary cells and mouse models of myeloproliferative neoplasms
作者
关键词
-
出版物
Blood Cancer Journal
Volume 1, Issue 7, Pages e29-e29
出版商
Springer Nature
发表日期
2011-07-22
DOI
10.1038/bcj.2011.29
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Myeloproliferative neoplasm induced by constitutive expression of JAK2V617F in knock-in mice
- (2010) C. Marty et al. BLOOD
- Conditional expression of heterozygous or homozygous Jak2V617F from its endogenous promoter induces a polycythemia vera-like disease
- (2010) H. Akada et al. BLOOD
- JAK2 V617F impairs hematopoietic stem cell function in a conditional knock-in mouse model of JAK2 V617F-positive essential thrombocythemia
- (2010) J. Li et al. BLOOD
- Preclinical characterization of the selective JAK1/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasms
- (2010) A. Quintas-Cardama et al. BLOOD
- Treatment options for hydroxyurea-refractory disease complications in myeloproliferative neoplasms: JAK2 inhibitors, radiotherapy, splenectomy and transjugular intrahepatic portosystemic shunt
- (2010) Elena Mishchenko et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Safety and Efficacy of INCB018424, a JAK1 and JAK2 Inhibitor, in Myelofibrosis
- (2010) Srdan Verstovsek et al. NEW ENGLAND JOURNAL OF MEDICINE
- Kinase selectivity potential for inhibitors targeting the ATP binding site: a network analysis
- (2009) Danzhi Huang et al. BIOINFORMATICS
- Src tyrosine kinase preactivation is associated with platelet hypersensitivity in essential thrombocythemia and polycythemia vera
- (2009) M. L. Randi et al. BLOOD
- Combined Inhibition of Janus Kinase 1/2 for the Treatment of JAK2V617F-Driven Neoplasms: Selective Effects on Mutant Cells and Improvements in Measures of Disease Severity
- (2009) P. C.C. Liu et al. CLINICAL CANCER RESEARCH
- Blood cell activation in myeloproliferative neoplasms
- (2009) F. Cervantes et al. HAEMATOLOGICA
- Identification of a novel TEL–Lyn fusion gene in primary myelofibrosis
- (2009) H Tanaka et al. LEUKEMIA
- Essential thrombocythemia, polycythemia vera, and myelofibrosis: Current management and the prospect of targeted therapy
- (2008) Ayalew Tefferi AMERICAN JOURNAL OF HEMATOLOGY
- Transgenic expression of JAK2V617F causes myeloproliferative disorders in mice
- (2008) S. Xing et al. BLOOD
- Dasatinib inhibits progenitor cell proliferation from polycythaemia vera
- (2008) M. Wappl et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Ratio of mutant JAK2-V617F to wild-type Jak2 determines the MPD phenotypes in transgenic mice
- (2007) R. Tiedt et al. BLOOD
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started